A Oneindia Venture
Click it and Unblock the Notifications
Akums Drugs & Pharmaceuticals Ltd. IPO
Akums Drugs & Pharmaceuticals Ltd., established in 2004, operates in the Pharmaceuticals sector. The company's IPO opened on July 30, 2024 and closed on August 1, 2024, with an issue price of ₹679. ... Read more
IPO Timeline
-
30 Jul 2024Bidding Starts
-
1 Aug 2024Bidding Ends
-
2 Aug 2024Allotment Finalization
-
6 Aug 2024Listing
About Akums Drugs & Pharmaceuticals Ltd.
We are a pharmaceutical contract development and manufacturing organization offering a comprehensive range of pharmaceutical products and services in India and overseas. We are also engaged in the sale of branded pharmaceutical formulations and manufacturing of active pharmaceutical ingredients. ... Read more
Akums Drugs & Pharmaceuticals Ltd. IPO Reservation
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 1,22,05,912 (44.64%) |
| Employee Reserved | 2,20,913 (0.81%) |
| Non Institutional Investors | 40,68,637 (14.88%) |
| Qualified Institutional Buyers (QIBs) | 81,37,275 (29.76%) |
| Retail Individual Investors (RIIs) | 27,12,425 (9.92%) |
Akums Drugs & Pharmaceuticals Ltd. Financial Information
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2024 | 1,538.24 Cr | -146.06 Cr | 115.27 Cr |
| 31 Mar 2023 | 1,382.98 Cr | 269.96 Cr | 282.89 Cr |
Akums Drugs & Pharmaceuticals Ltd. Background
-
2004Incorporation of the Company
Established first plant for oral dosage commissioned at 19, 20, 21, sector 6A, Haridwar, Uttarakhand
-
2007Established dedicated manufacturing site for oral liquid dosage at 22, Sector 6A, Sidcul, Haridwar, Uttarakhand and sterile products at 2,3,4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand
-
2009Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals
-
2010Dedicated a facility for hormones at 48, Sector 6A, SIDCUL, Haridwar, Uttarakhand
Dedicated a facility for cosmetics and dermatology at 47, Sector 6A, SIDCUL, Haridwar, Uttarakhand
Incorporated Akumentis Healthcare Limited to venture into branded formulations
-
2011Innovated bi-layered sustained release tablets for the first time
-
2012Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities
-
2013Innovated tablet-in-tablet sustained release tablets for the first time
Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities
Expanded into the African market
-
2015Expanded into the Asian market
Established research and development laboratory in Mumbai, Maharashtra to venture into regulated market
-
2016Maxcure Nutravedics Limited received US-NSF certification
-
2019Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder
-
2021Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs
Acquisition of a facility at Kotdwar, Uttarakhand by Akums Healthcare Limited
-
2022Plant at 19, 20, 21, Sector 6A, SIDCUL, Haridwar, Uttarakhand and plant at 2, 3, 4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand accredited European Union-Good Manufacturing Practices, qualifying for exports to European markets
Acquisition of a facility in Haridwar, Uttarakhand by Akums Healthcare Limited and a facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited
-
2023Acquisition of another facility in Baddi, Himachal Pradesh by Pure and Cure Healthcare Private Limited
Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited
1. Repayment/prepayment of all or certain borrowings of our Company
2. Repayment/prepayment of all or certain borrowings of our Subsidiaries namely, Maxcure Nutravedics Limited and Pure and Cure Healthcare Private Limited
3. Funding incremental working capital requirements of our Company
4. Pursuing inorganic growth initiatives through acquisitions
5. General corporate purposes
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | ₹ 679.00 | ₹ 679.00 |
| Open | ₹ 725.00 | ₹ 725.00 |
| Low | ₹ 724.50 | ₹ 725.00 |
| High | ₹ 797.45 | ₹ 797.50 |
| Last Trade | ₹ 796.35 | ₹ 796.25 |
1. Sanjeev Jain
2. Sandeep Jain
3. Akums Master Trust
The pharmaceutical industry in India is characterized by significant challenges, including, high capital expenditure required to establish and maintain sizeable manufacturing units, research and development expertise, trained manpower, consistent quality control, pricing pressure, disruptions ... Read more
Phone no:69041000
FAQs
When does Akums Drugs & Pharmaceuticals Ltd. IPO opens and closes?
What is the size of Akums Drugs & Pharmaceuticals Ltd. IPO?
What is the price range of Akums Drugs & Pharmaceuticals Ltd. IPO?
What is the minimum investment and lot size required for the Akums Drugs & Pharmaceuticals Ltd. IPO?
When is Akums Drugs & Pharmaceuticals Ltd. IPO listing date?
What is the objective of Akums Drugs & Pharmaceuticals Ltd. IPO?
2. Repayment/prepayment of all or certain borrowings of our Subsidiaries namely, Maxcure Nutravedics Limited and Pure and Cure Healthcare Private Limited
3. Funding incremental working capital requirements of our Company
4. Pursuing inorganic growth initiatives through acquisitions
5. General corporate purposes
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
NSE IPO 2026: OFS Window Opens, April 27 Deadline Key for Shareholders; Check Eligibility, Lock-in Rules -
CMPDI IPO Lists at 7% Discount on NSE, BSE; Weak Demand Keeps Stock Under Pressure Despite Mild Recovery -
CMPDI IPO Allotment Today: Did You Get Shares? Check Status Now on KFin, NSE, BSE -
Powerica IPO Off to Slow Start: GMP Up 1.2%, But Subscription Stuck at 0.01x; Is It Worth Applying? -
CMPDI IPO Underwhelms: Day 2 Subscription At 10%, No Movement In GMP; What's Behind The Weak Demand? -
Upcoming IPOs Next Week: CMPDI, Sai Parenteral, Powerica, Vivid Electromech, More | Check Full List -
XED Executive Development IPO: GIFT City Sees First IPO; Price Band, Issue Size | All You Need to Know -
Skyways Air IPO vs CMPDI IPO: Full Comparison of Price Band, GMP, Lot Size, Listing & Allotment Date -
Coal India's CMPDI IPO GMP Shows 11% Listing Gain Potential; Everything You Need To Know -
Big Change in IPO Rules: Govt Updates Minimum Public Offer Norms for for IPO-bound Firms
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Sign in with Google- Male
- Female
- Others
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+